Results 341 to 350 of about 98,296 (378)

Adverse Effects of Bisphosphonates

Calcified Tissue International, 2010
Use of bisphosphonates has been growing steadily in the last decade. This follows the introduction of simpler dosing regimes, the availability of lower-priced generics, and concerns about the safety of hormone-replacement therapy. Bisphosphonates have a relatively good safety record and are tolerated by the majority of patients, but serious adverse ...
Bo Abrahamsen, Bo Abrahamsen
openaire   +5 more sources

Toxicity of Bisphosphonates

Journal of Palliative Medicine, 2009
Bisphosphonates have become an important treatment for the palliation of metastatic bone disease. Their increasing use has lead to the recognition of toxicities that can lead to substantial morbidity for the patient with advanced cancer. This case presentation highlights toxicities associated with bisphosphonate use and provides some guidelines on the ...
openaire   +3 more sources

An update on bisphosphonates

Current Rheumatology Reports, 2004
Over the past 15 years, bisphosphonates have been demonstrated as effective therapy for the treatment of osteoporosis based on their ability to suppress bone turnover resulting in increased bone mineral content and increased bone strength. The mechanism of action at the cellular level has been identified, and the more potent nitrogen-containing ...
openaire   +3 more sources

Bisphosphonate Treatment of Osteoporosis

Clinics in Geriatric Medicine, 2000
Bisphosphonates represent the agents of choice for most patients with osteoporosis. They are the best studied of all agents for the prevention of bone loss and reduction in fractures. They increase BMD, primarily at the lumbar spine, but also at the proximal femur.
openaire   +3 more sources

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Journal of oral and maxillofacial surgery, 2009
S. Ruggiero, T. Dodson, L. Assael, R. Landesberg, R. Marx, B. Mehrotra   +5 more
semanticscholar   +1 more source

TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES

Rheumatic Disease Clinics of North America, 1994
Several bisphosphonates are effective for preventing bone loss associated with estrogen deficiency, glucocorticoid treatment, and immobilization, and for at least partially reversing bone loss in patients with postmenopausal osteoporosis and steroid-induced osteoporosis.
openaire   +6 more sources

Consensus guidelines on the use of bisphosphonate therapy in children and adolescents

Journal of Paediatrics and Child Health, 2018
P. Simm, A. Biggin, M. Zacharin, C. Rodda, Elaine Tham, A. Siafarikas, C. Jefferies, P. Hofman, D. Jensen, H. Woodhead, Justin Brown, B. Wheeler, D. Brookes, A. Lafferty, C. Munns   +14 more
semanticscholar   +1 more source

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Journal of oral and maxillofacial surgery, 2005
R. Marx, Y. Sawatari, M. Fortin, V. Broumand   +3 more
semanticscholar   +1 more source

A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

Osteoporosis International, 2017
T. Hasegawa, A. Kawakita, N. Ueda, R. Funahara, A. Tachibana, M. Kobayashi, E. Kondou, D. Takeda, Y. Kojima, S. Sato, S. Yanamoto, H. Komatsubara, M. Umeda, T. Kirita, H. Kurita, Y. Shibuya, T. Komori, Japanese Study Group of Co-operative Dentistry with Medicine   +17 more
semanticscholar   +1 more source

Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro

Clinical Oral Investigations, 2018
Junho Jung, J. Park, L. Righesso, A. Pabst, B. Al‐Nawas, Yong-Dae Kwon, C. Walter   +6 more
semanticscholar   +1 more source